ArticleScience translational medicine2012

Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.

Christina Henderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.